Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma

被引:68
作者
Röijer, E
Nordkvist, A
Ström, AK
Ryd, W
Behrendt, M
Bullerdiek, J
Mark, J
Stenman, G
机构
[1] Univ Gothenburg, Dept Pathol, Lundberg Lab Canc Res, Gothenburg, Sweden
[2] Univ Bremen, Ctr Human Genet & Genet Counseling, Bremen, Germany
关键词
D O I
10.1016/S0002-9440(10)64862-6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Carcinoma ex pleomorphic adenoma (CexPA) is a carcinoma developing within a pre-existing benign pleomorphic adenoma (PA). Here we describe the identification and characterization of a series of genetic events leading to translocation, deletion/amplification, and overexpression of the HMGIC and MDM2 genes in a CexPA at an early stage of development. The tumor had a pseudodiploid stemline karyotype with a del(5)(q22-23q32-33) and a t(10;12)(p15; q14-15). In addition, there were several sidelines with double minute chromosomes (dmin) or homogeneously staining regions (hsr). Fluorescence in situ hybridization (FISH) mapping revealed that the 12q14-15 breakpoint was located centromeric to HMGIC and that the entire gene was juxtaposed to the der(10) chromosome. Detailed analysis of cells with dmin and hsr revealed that HMGIC and MDM2 were deleted from the der(10) and that the dmin and hsr were strongly positive for both genes. Southern blot analysis confirmed that both HMGIC and MDM2 were amplified and that no gross rearrangements of the genes had occurred. Immunostaining revealed that the HMGIC protein was highly overexpressed particularly in the large polymorphic cells within the carcinomatous part of the tumor. These findings suggest that amplification and overexpression of HMGIC and possibly MDM2 might be important genetic events that may contribute to malignant transformation of benign PA.
引用
收藏
页码:433 / 440
页数:8
相关论文
共 52 条
[1]  
ALDRON CA, 1991, SURG PATHOLOGY SALIV, P165
[2]  
ASHAR HR, 1995, CELL, V82, P57
[3]  
Åström AK, 1999, CANCER RES, V59, P918
[4]   HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas [J].
Berner, JM ;
MezaZepeda, LA ;
Kools, PFJ ;
Forus, A ;
Schoenmakers, EFPM ;
VandeVen, WJM ;
Fodstad, O ;
Myklebost, O .
ONCOGENE, 1997, 14 (24) :2935-2941
[5]   MUCOEPIDERMOID TUMOR OF THE PAROTID-GLAND SHOWING A TRANSLOCATION (3, 8)(P21, Q12) AND A DELETION (5)(Q22) AS SOLE CHROMOSOME-ABNORMALITIES [J].
BULLERDIEK, J ;
VOLLRATH, M ;
WITTEKIND, C ;
CASELITZ, J ;
BARTNITZKE, S .
CANCER GENETICS AND CYTOGENETICS, 1990, 50 (01) :161-164
[6]   CYTOGENETIC SUBTYPING OF 220 SALIVARY-GLAND PLEOMORPHIC ADENOMAS - CORRELATION TO OCCURRENCE, HISTOLOGICAL SUBTYPE, AND INVITRO CELLULAR BEHAVIOR [J].
BULLERDIEK, J ;
WOBST, G ;
MEYERBOLTE, K ;
CHILLA, R ;
HAUBRICH, J ;
THODE, B ;
BARTNITZKE, S .
CANCER GENETICS AND CYTOGENETICS, 1993, 65 (01) :27-31
[7]   CYTOGENETIC INVESTIGATIONS ON A CELL-LINE DERIVED FROM A CARCINOMA ARISING IN A SALIVARY-GLAND PLEOMORPHIC ADENOMA [J].
BULLERDIEK, J ;
HUTTER, KJ ;
BRANDT, G ;
WEINBERG, M ;
BELGE, G ;
BARTNITZKE, S .
CANCER GENETICS AND CYTOGENETICS, 1990, 44 (02) :253-262
[8]   DOUBLE MINUTE CHROMOSOMES CAN BE PRODUCED FROM PRECURSORS DERIVED FROM A CHROMOSOMAL DELETION [J].
CARROLL, SM ;
DEROSE, ML ;
GAUDRAY, P ;
MOORE, CM ;
NEEDHAMVANDEVANTER, DR ;
VONHOFF, DD ;
WAHL, GM .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (04) :1525-1533
[9]  
CHIAPPETTA G, 1995, ONCOGENE, V10, P1307
[10]  
CORDONCARDO C, 1994, CANCER RES, V54, P794